Hsbc Holdings PLC Takes Position in Alexandria Real Estate Equities, Inc. $ARE

Hsbc Holdings PLC bought a new stake in shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE) during the 2nd quarter, according to its most recent filing with the SEC. The firm bought 1,208,572 shares of the real estate investment trust’s stock, valued at approximately $64,485,000. Hsbc Holdings PLC owned 0.69% of Alexandria Real Estate Equities as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Canada Pension Plan Investment Board acquired a new stake in Alexandria Real Estate Equities in the second quarter valued at approximately $56,969,000. Legal & General Group Plc acquired a new position in shares of Alexandria Real Estate Equities during the second quarter worth $76,647,000. The Manufacturers Life Insurance Company acquired a new stake in Alexandria Real Estate Equities during the 2nd quarter valued at $7,213,000. Cetera Trust Company N.A acquired a new stake in Alexandria Real Estate Equities during the 2nd quarter valued at $94,000. Finally, Algert Global LLC increased its stake in Alexandria Real Estate Equities by 38.8% during the 2nd quarter. Algert Global LLC now owns 144,310 shares of the real estate investment trust’s stock worth $7,627,000 after buying an additional 40,320 shares during the period. 96.54% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Alexandria Real Estate Equities

Here are the key news stories impacting Alexandria Real Estate Equities this week:

• Positive Sentiment: Baird raised its price target to $52. Robert W. Baird increased its target for ARE, signaling somewhat improved expectations for the life-science REIT, although the new target remains close to the stock’s recent trading level and the broader analyst view is still cautious. Robert W. Baird Boosts Alexandria Real Estate Equities Price Target to $52
• Positive Sentiment: One upward earnings revision provides modest support. Zacks Research raised its FY2026 EPS forecast to $6.39 from $6.36, slightly above the current consensus estimate of $6.38. However, Zacks maintained a “Hold” rating.
• Neutral Sentiment: Third-quarter results date announced. Alexandria will release its third-quarter 2026 operating and financial results and host its conference call on October 27, giving investors a scheduled catalyst to assess leasing, property sales, occupancy and guidance. Alexandria Announces Third-Quarter 2026 Earnings Call Date
• Neutral Sentiment: Cambridge asset sale provides liquidity. Alexandria sold lab condominium units in Cambridge, Massachusetts, to Draper for $45 million. The transaction may support liquidity and portfolio repositioning, but its effect on recurring earnings depends on the asset’s prior contribution and sale terms. Alexandria Sells Cambridge Lab Condo Units for $45 Million
• Negative Sentiment: Analysts lowered most medium- and long-term forecasts. Zacks cut estimates for Q3 and Q4 2026, every quarter of 2027, FY2027 to $5.16 from $5.56, and FY2028 to $5.47 from $5.62. The revisions suggest pressure on Alexandria’s earnings outlook and are likely the main fundamental drag on the stock.
• Negative Sentiment: Cambridge sale reportedly involved a $75 million loss. The reported loss substantially exceeds the $45 million sale proceeds, highlighting potential valuation pressure in Alexandria’s lab-property portfolio and raising concerns about realized asset values. Draper Buys Cambridge Lab Floors as Alexandria Takes a Loss

Analyst Ratings Changes

ARE has been the subject of a number of analyst reports. Wall Street Zen cut shares of Alexandria Real Estate Equities from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. BNP Paribas Exane boosted their price target on Alexandria Real Estate Equities from $45.00 to $48.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 5th. The Goldman Sachs Group reissued a “neutral” rating and issued a $52.00 price target on shares of Alexandria Real Estate Equities in a report on Tuesday, May 19th. Royal Bank Of Canada dropped their price objective on Alexandria Real Estate Equities from $60.00 to $50.00 and set a “sector perform” rating on the stock in a report on Tuesday, May 5th. Finally, Robert W. Baird upped their target price on Alexandria Real Estate Equities from $46.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Alexandria Real Estate Equities presently has a consensus rating of “Reduce” and a consensus target price of $52.85.

Alexandria Real Estate Equities Trading Up 0.1%

Alexandria Real Estate Equities stock opened at $52.95 on Thursday. Alexandria Real Estate Equities, Inc. has a 1 year low of $39.41 and a 1 year high of $88.24. The firm’s 50-day moving average is $50.71 and its 200-day moving average is $49.57. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.19 and a current ratio of 0.19. The company has a market cap of $9.23 billion, a P/E ratio of -8.74 and a beta of 1.15.

Alexandria Real Estate Equities (NYSE:ARE) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.43) earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.52). Alexandria Real Estate Equities had a negative net margin of 36.08% and a negative return on equity of 5.21%. The business had revenue of $662.78 million for the quarter, compared to the consensus estimate of $464.86 million. During the same period in the prior year, the company earned $2.33 EPS. Alexandria Real Estate Equities’s quarterly revenue was down 13.0% on a year-over-year basis. Alexandria Real Estate Equities has set its FY 2026 guidance at 6.350-6.450 EPS. On average, equities analysts expect that Alexandria Real Estate Equities, Inc. will post 6.38 earnings per share for the current year.

Alexandria Real Estate Equities Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.88 annualized dividend and a dividend yield of 5.4%. Alexandria Real Estate Equities’s dividend payout ratio is -47.52%.

Insider Buying and Selling

In related news, Chairman Joel S. Marcus acquired 5,000 shares of Alexandria Real Estate Equities stock in a transaction that occurred on Monday, August 17th. The stock was acquired at an average price of $46.28 per share, for a total transaction of $231,400.00. Following the transaction, the chairman directly owned 592,724 shares of the company’s stock, valued at $27,431,266.72. This trade represents a 0.85% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Marc E. Binda sold 2,000 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $54.00, for a total value of $108,000.00. Following the transaction, the chief financial officer owned 188,264 shares of the company’s stock, valued at approximately $10,166,256. The trade was a 1.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.35% of the stock is currently owned by corporate insiders.

Alexandria Real Estate Equities Profile

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.